(VIANEWS) – SANOFI (SAN.PA), OENEO (SBT.PA), AKZO NOBEL (AKZA.AS) are the highest payout ratio stocks on this list.
We have gathered information about stocks with the highest payout ratio at the moment. The payout ratio in itself isn’t a promise of good investment but it’s an indicator of whether dividends are being paid and how the company chooses to issue them.
When researching a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.
1. SANOFI (SAN.PA)
98.61% Payout Ratio
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers products for itching, hydration, aging, cracking, overnight, and specialty skincare needs like eczema. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Adagene Inc., for the discovery and development of antibody-based therapies. It also has collaborations with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, SANOFI has a trailing twelve months EPS of €4.3.
PE Ratio
SANOFI has a trailing twelve months price to earnings ratio of 21.15. Meaning, the purchaser of the share is investing €21.15 for every euro of annual earnings.
Sales Growth
SANOFI’s sales growth for the next quarter is 7.3%.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on May 13, 2024, the estimated forward annual dividend rate is 3.76 and the estimated forward annual dividend yield is 4.22%.
More news about SANOFI.
2. OENEO (SBT.PA)
67.31% Payout Ratio
Oeneo SA operates in the wine industry worldwide. The company manufactures and sale of cork closures. It also provides products and solutions in wine making and spirits. Oeneo SA is headquartered in Bordeaux, France. Oeneo SA operates as a subsidiary of Caspar SAS.
Earnings Per Share
As for profitability, OENEO has a trailing twelve months EPS of €0.52.
PE Ratio
OENEO has a trailing twelve months price to earnings ratio of 19.81. Meaning, the purchaser of the share is investing €19.81 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.68%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Oct 3, 2023, the estimated forward annual dividend rate is 0.35 and the estimated forward annual dividend yield is 2.99%.
Moving Average
OENEO’s value is below its 50-day moving average of €10.38 and way under its 200-day moving average of €12.19.
More news about OENEO.
3. AKZO NOBEL (AKZA.AS)
63.67% Payout Ratio
Akzo Nobel N.V. engages in the production and sale of paints and coatings worldwide. The company operates through two segments: Decorative Paints and Performance Coatings. It offers decorative paints, including paints, lacquers, and varnishes; and a range of mixing machines and color concepts for the building and renovation industry, as well as specialty coatings. The company also provides performance coatings that protect and enhance ships, cars, aircraft, yachts, architectural components, consumer goods, and oil and gas facilities. It offers its products under AkzoNobel, Alabastine, Alba, Andercol, Apla, Armstead Trade, Astral, Astral Batiment, AwlGrip, Brikol, Dulux, Bruguer, Cetabever, Cetol, Chemcraft, Colourland Paints, CONSOLAN, Coral, Cromadex, Cuprinol, Dynacoat, Flexa, Glitsa, Grip-Gard, Herbol, Hammerite, International, Interlux, Innenweis, Interpon, Inca, Luxol, Levis, Lesonal, Molto, Modern Classikk, Maxilite, Mauvilac, Mason CT, Marshall, Mactra, Nordsjo, Oxirite, Protecto, Procolor, Polyfilla, Polycell, Pinotex, Pintuco, Resicoat, Relest, Sparlack, Sadolin, Sikkens, Sea Hawk, Savana, Salcomix, Trimetal, Titanlux, Taubmans, U-tech, Vpowdertech, Vivechrom, Xylazel, Xyladecor, Wanda, and Zweihorn brands. The company serves to energy, packaging, infrastructure, and shipbuilding and maintenance industries, as well as general industries, such as agricultural and construction equipment, construction-related steel, metal fabrication, pipes, appliances, and transportation. The company was formerly known as Akzo NV and changed its name to Akzo Nobel N.V. in 1994. Akzo Nobel N.V. was founded in 1646 and is headquartered in Amsterdam, the Netherlands.
Earnings Per Share
As for profitability, AKZO NOBEL has a trailing twelve months EPS of €3.11.
PE Ratio
AKZO NOBEL has a trailing twelve months price to earnings ratio of 20.84. Meaning, the purchaser of the share is investing €20.84 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.21%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 30.1% and 25.3%, respectively.
Moving Average
AKZO NOBEL’s worth is below its 50-day moving average of €65.67 and under its 200-day moving average of €68.80.
Yearly Top and Bottom Value
AKZO NOBEL’s stock is valued at €64.82 at 02:10 EST, way below its 52-week high of €79.32 and higher than its 52-week low of €60.06.
Revenue Growth
Year-on-year quarterly revenue growth declined by 0.6%, now sitting on 10.65B for the twelve trailing months.
More news about AKZO NOBEL.
4. IPSOS (IPS.PA)
37.6% Payout Ratio
Ipsos SA, through its subsidiaries, provides survey-based research services for companies and institutions in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company offers services in the information production and analysis chain, including data collection, data processing and integration, data analysis, information delivery and presentation, and information activation. It also provides audience measurement, automotive and mobility development, brand health tracking, channel performance, corporate reputation, creative excellence, customer experience, healthcare, innovation, Ipsos MMA, Ipsos UU, market strategy and understanding, observer, public affairs, social intelligence analytics, and other specialist services, as well as research methodologies, such as device agnosticism, programmatic sampling, and digital face-to-face interview. In addition, the company offers online and mobile integrated services and device agnostic solutions that include online surveys adapted to laptops, smartphones, and tablets; and qualitative research services, as well as operates Ipsos.Digital, a do-it-yourself platform. Further, it provides artificial intelligence and data science solutions that develops and provides analytical tools based on data science, machine learning, big analytics, and modelling; and behavioral science and neuroscience solutions, as well as operates Ipsos Knowledge Centre for teams and clients. Ipsos SA was incorporated in 1975 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, IPSOS has a trailing twelve months EPS of €3.59.
PE Ratio
IPSOS has a trailing twelve months price to earnings ratio of 18.2. Meaning, the purchaser of the share is investing €18.2 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.29%.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Jul 1, 2024, the estimated forward annual dividend rate is 1.65 and the estimated forward annual dividend yield is 2.46%.
More news about IPSOS.
5. CRCAM ATL.VEND.CCI (CRAV.PA)
34.35% Payout Ratio
Caisse régionale de Crédit Agricole Mutuel Atlantique Vendée provides banking products and services in France. It offers accounts and card services; real estate loan and consumer credit products; and life insurance products. The company also provides real estate investment, and stock exchange and financial investment services, as well as retirement saving solutions. It serves individuals, private banks, businesses, professionals, farmers, public community and social housing, and associations. The company was incorporated in 2001 and is headquartered in Nantes, France. Caisse régionale de Crédit Agricole Mutuel Atlantique Vendée operates as a subsidiary of Crédit Agricole S.A.
Earnings Per Share
As for profitability, CRCAM ATL.VEND.CCI has a trailing twelve months EPS of €13.62.
PE Ratio
CRCAM ATL.VEND.CCI has a trailing twelve months price to earnings ratio of 5.92. Meaning, the purchaser of the share is investing €5.92 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.37%.
Moving Average
CRCAM ATL.VEND.CCI’s worth is below its 50-day moving average of €84.42 and below its 200-day moving average of €86.22.
Yearly Top and Bottom Value
CRCAM ATL.VEND.CCI’s stock is valued at €80.60 at 02:10 EST, way under its 52-week high of €99.50 and way above its 52-week low of €72.60.
Volume
Today’s last reported volume for CRCAM ATL.VEND.CCI is 637 which is 102.86% above its average volume of 314.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on May 15, 2024, the estimated forward annual dividend rate is 3.71 and the estimated forward annual dividend yield is 4.05%.
More news about CRCAM ATL.VEND.CCI.
6. EIFFAGE (FGR.PA)
34.19% Payout Ratio
Eiffage SA engages in the construction, property development, urban development, civil engineering, metallic construction, roads, energy systems, and concessions businesses in France and internationally. The company operates through Construction, Infrastructure, Energy Systems, Concessions, and Holding Company segments. The Construction segment offers urban development, building design and construction, property development, and maintenance and facilities management services. The Infrastructure segment is involved in undertaking civil engineering, road and rail design and construction, drainage, earthworks, and metallic construction. The Energy Systems segment designs, constructs, integrates, operates, and maintains energy and telecommunication systems and equipment. The Concessions segment constructs and manages concession contracts and public-private partnerships. The company was founded in 1844 and is based in Vélizy-Villacoublay, France.
Earnings Per Share
As for profitability, EIFFAGE has a trailing twelve months EPS of €10.65.
PE Ratio
EIFFAGE has a trailing twelve months price to earnings ratio of 9.87. Meaning, the purchaser of the share is investing €9.87 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.94%.
Moving Average
EIFFAGE’s worth is above its 50-day moving average of €102.32 and way higher than its 200-day moving average of €95.24.
Yearly Top and Bottom Value
EIFFAGE’s stock is valued at €105.15 at 02:10 EST, below its 52-week high of €107.75 and way higher than its 52-week low of €82.18.
More news about EIFFAGE.
1. 1 (1)
1% Payout Ratio
1
Earnings Per Share
As for profitability, 1 has a trailing twelve months EPS of €1.
PE Ratio
1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing €1 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Jan 1, 1970, the estimated forward annual dividend rate is 1 and the estimated forward annual dividend yield is 1%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 1%, now sitting on 1 for the twelve trailing months.
More news about 1.
